Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-07-17 / Am. J. Ophthalmol. 2014 Nov;158(5):939-47ISG12a mediates cell response to Newcastle disease viral infection
/in International Publications, Newcastle Disease Virus /von 2014-07-05 / Virology 2014 Aug;462-463:283-94Going viral with cancer immunotherapy
/in International Publications, Newcastle Disease Virus /von 2014-07-03 / Nat. Rev. Cancer 2014 Aug;14(8):559-67Melanoma cell lysate induces CCR7 expression and in vivo migration to draining lymph nodes of therapeutic human dendritic cells
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-07-01 / Immunology 2014 Jul;142(3):396-405Identification of pancreatic cancer-associated tumor antigen from HSP-enriched tumor lysate-pulsed human dendritic cells
/in Dendritic Cells, Hyperthermia, International Publications, Pancreatic Cancer /von 2014-07-01 / Yonsei Med. J. 2014 Jul;55(4):1014-27Noninvasive radiofrequency treatment effect on mitochondria in pancreatic cancer cells
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2014-07-01 / Cancer 2014 Nov;120(21):3418-25Therapeutic DC vaccination with IL-2 as a consolidation therapy for ovarian cancer patients: a phase I/II trial
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2014-06-30 / Cell. Mol. Immunol. 2015 Jan;12(1):87-95Autologous tumor vaccine modified with recombinant new castle disease virus expressing IL-7 promotes antitumor immune response
/in International Publications, Newcastle Disease Virus /von 2014-06-18 / J. Immunol. 2014 Jul;193(2):735-45Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer
/in International Publications, Newcastle Disease Virus /von 2014-06-11 / Front Oncol 2014;4:145IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de